These findings underline the importance of SORT1 in cancer cell proliferation pathways and the need for targeted therapeutic approaches that exploit these unique properties of SORT1, offering a promising avenue for refining diagnostic tools and therapeutic strategies in the management of ovarian carcinoma [77, 78]. The gene discussed is SORT1; the disease is ovarian carcinoma.